Geom Therapeutics
San Francisco, US · Founded 2015 · Delaware corporation
Founders & leadership
DT
Dirk ThyeExecutive
Board
DG
Dov GoldsteinBoard director
SP
Sejin ParkBoard director
YK
Yong-Zu KimBoard director
CC
Cooper CollinsBoard director
Reported raises · per SEC filings
Form D private placements$4.4M disclosed across 1 round · 2017
▶$4.4MraisedApr 2017 · 17 investors · BiotechnologyRule 506(b)
▶$4.4MraisedApr 2017 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Yong-Zu KimDirector
- Cooper CollinsDirector
- Dov GoldsteinDirector
- Dirk ThyeExecutive Officer, Director
- Sejin ParkDirector
- Offering amount
- $4.5M
- Amount sold
- $4.4M
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Geom Therapeutics raised?
- Geom Therapeutics has disclosed $4.4M raised across 1 round.
- Where is Geom Therapeutics headquartered?
- Geom Therapeutics is headquartered in San Francisco, US.